Randomized Controlled Study of Cooled vs Room-Temperature Artificial Tears for Reducing Ocular Surface Irritation After Intravitreal Injection.
Smrithi ManiHaoxing D JinBryce ShonkaChristopher R FortenbachJonathan F RussellPublished in: Journal of vitreoretinal diseases (2023)
Purpose: To evaluate the efficacy of cooled vs room-temperature artificial tears in reducing ocular discomfort after intravitreal injections (IVIs). Methods: Patients receiving a standard intravitreal injection in the retina clinic who met the eligibility criteria and provided informed consented were enrolled in the study. Patients were randomized to the cooled tears or room-temperature tears intervention group. Both groups rated their ocular discomfort following IVI after cooled or room-temperature tears were administered. Results: The cooled group comprised 48 patients and the room-temperature group, 61 patients. There was no significant difference in the reduction of ocular discomfort between the cooled vs room-temperature artificial tears groups ( P = .387). In addition, there was a similar level of reduction in ocular discomfort after either intervention ( P = .681) regardless of whether or not the patients routinely used artificial tears after previous IVIs. Conclusions: Cooled tears provided no additional benefit in reducing ocular discomfort post-IVI compared with room-temperature tears. Baseline tear use after an IVI may have no true benefit other than a potential placebo effect, recall bias, or both.
Keyphrases
- room temperature
- end stage renal disease
- ionic liquid
- rotator cuff
- ejection fraction
- chronic kidney disease
- newly diagnosed
- peritoneal dialysis
- randomized controlled trial
- prognostic factors
- primary care
- double blind
- open label
- study protocol
- risk assessment
- vascular endothelial growth factor
- ultrasound guided
- climate change
- patient reported
- phase iii